In the current study, we generated a transgenic mouse line that overexpresses SYVN1 and used these mice to study the protective role of SYVN1 against DR by inducing diabetes using streptozotocin (STZ) injection. The gene discussed is SYVN1; the disease is diabetes mellitus.